BONS: Bonus BioGroup Ltd. - Summary | Jitta

Bonus BioGroup Ltd.

ISR:BONS

Price
₪0.41
Loss Chance
59.1%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (19)
Recent Business Performance (33)
Financial Strength (30)
Return to Shareholders (13)
Competitive Advantage (16)
Jitta Signs
Cash Conversion CycleLess than 30 days
CapExVery High
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
1.58
85.44%
2.84
95.01%
Biotechnology
1.84
100.00%
0.58
100.00%
1.38
100.00%
COMPANY DESCRIPTION
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase III clinical trial, as well as in preclinical stage for the treatment of other inflammations and tissue damage, including chronic kidney diseases, osteoarthritis, and cytokine release syndrome. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is headquartered in Haifa, Israel.